RxDoctor Payments Data

Stephanie Drafts Pellegrino, APRN

Psychiatric/Mental Health · Fort Myers, FLNPI 1417613647

Payments from drug & device makers

$2,046in general payments, 2019–2025

Across 113 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$578
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$340
  • Johnson & Johnson$242
  • Teva Pharmaceuticals USA, Inc.$179
  • Neurocrine Biosciences, Inc.$161
  • Alkermes, Inc.$160
  • plus $388 from 6 others

What the payments were for

  • Food & beverage$1,87592%
  • Education$1718%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,046 in reported general payments places this provider in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$10,563
Medicare patients
57
Services billed
149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine28$324,551
Invega SustennaPaliperidone Palmitate34$102,477
VraylarCariprazine Hcl45$82,215
Abilify MaintenaAripiprazole15$35,175
Aripiprazole150$17,887
Lurasidone Hcl19$14,530
Divalproex Sodium ErDivalproex Sodium54$4,100
Atomoxetine Hcl17$2,536
Quetiapine Fumarate119$2,456
Trazodone Hcl164$2,233
Oxcarbazepine42$2,232
Buspirone Hcl154$1,860
Vilazodone Hcl15$1,791
Bupropion XlBupropion Hcl90$1,771
Haloperidol Decanoate21$1,620

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$179$324,55128 claims
Johnson & JohnsonInvega Sustenna$242$102,47734 claims
AbbVieVraylar$578$82,21545 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$115$35,17515 claims
Almatica Pharma LLCSertraline Hcl$63$768147 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →